Andrew Tepperman is a vice president in CRA’s Life Sciences Practice. Dr. Tepperman has considerable experience conducting economic analyses in intellectual property and antitrust matters as well as in the context of other commercial disputes. His work has encompassed a variety of industries, including pharmaceuticals, biologics, medical devices, telecommunications, and computer hardware and software. He has provided expert testimony in Canadian and U.S. court proceedings. Before joining CRA in 2001, Dr. Tepperman lectured at the University of Toronto and conducted research funded by Industry Canada on the international determinants of patenting.